Safety and Effectiveness of the XEN45 Glaucoma Treatment System in Patients With Angle Closure Glaucoma
Clinical trial NCT03362931 · COMPLETED
Trial details
- NCT number
- NCT03362931
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-19
- Primary completion
- 2022-03-18
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.